https://www.zaobao.com.sg/finance/china/story20251207-7928389?ref=global-finance; last accessed: 20251208

> 中国发布首版商保创新药目录 礼来辉瑞强生被列入

China publishes the first edition of the list of new and innovative drugs covered by commercial insurance, medicines from Eli Lilly, Pfizer and Johnson & Johnson have been included in this list

> 发布/2025年12月7日 18:05

Published: 2025-12-07T18:05

## --

>（广州综合讯）中国发布首版《商业健康保险创新药品目录》，纳入18家创新药企的19个药品。美国制药巨头礼来、辉瑞、强生和日本卫材等相关药品进入名单。

(Guangzhou News) China has published the first edition of "The Commercial Health Insurance's List of New and Innovative Drugs," which includes 19 drugs from 18 innovative pharmaceutical companies. Medicines from US-regulated giants Eli Lilly, Pfizer, Johnson & Johnson and Eisai Japan, among others, are in this list.

> 综合彭博社、南方网和澎湃新闻报道，中国2025创新药高质量发展大会星期天（12月7日）在广州召开。大会公布，中国今年以来批准上市的创新药达69个，再次创下历史新高。

Bloomberg, Southern Network and The Paper have reported that China held last Sunday (12/7) in Guangzhou the 2025 High-Quality Innovative Drugs Development Conference, which published the 69 new drugs that China has approved for release into the market beginning this year. The figure is again the highest in recorded history.

> 大会也发布上述目录，涵盖肿瘤、罕见病、慢性病治疗以及备受关注的阿尔茨海默症药品等。

The aforementioned list published by the conference covered treatments such as those for tumors, rare and chronic diseases as well as medication for Alzheimer's, a disease that has garnered considerable attention recently.

More...

## REFERENCE

1) BAIDU SEARCH ENGINE; TRANSLATE

2) GOOGLE SEARCH ENGINE; TRANSLATE

3) PLECO ANDROID APP